BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24064382)

  • 1. Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanism.
    Huang JS; Cho CY; Hong CC; Yan MD; Hsieh MC; Lay JD; Lai GM; Cheng AL; Chuang SE
    Free Radic Biol Med; 2013 Dec; 65():1246-1256. PubMed ID: 24064382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.
    Li W; Xiong X; Abdalla A; Alejo S; Zhu L; Lu F; Sun H
    J Biol Chem; 2018 Oct; 293(40):15397-15418. PubMed ID: 30108175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma.
    Cooke M; Kreider-Letterman G; Baker MJ; Zhang S; Sullivan NT; Eruslanov E; Abba MC; Goicoechea SM; García-Mata R; Kazanietz MG
    Cell Rep; 2021 Nov; 37(5):109905. PubMed ID: 34731623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells.
    Pénzes K; Baumann C; Szabadkai I; Orfi L; Kéri G; Ullrich A; Torka R
    Cancer Biol Ther; 2014; 15(11):1571-82. PubMed ID: 25482942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.
    Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-induced downregulation of Axl receptor tyrosine kinase inhibits cell proliferation and circumvents chemoresistance in non-small lung cancer cells.
    Kim KC; Baek SH; Lee C
    Int J Oncol; 2015 Dec; 47(6):2296-303. PubMed ID: 26498137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression.
    Kong L; Wu Z; Zhao Y; Lu X; Shi H; Liu S; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31110076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
    Hector A; Montgomery EA; Karikari C; Canto M; Dunbar KB; Wang JS; Feldmann G; Hong SM; Haffner MC; Meeker AK; Holland SJ; Yu J; Heckrodt TJ; Zhang J; Ding P; Goff D; Singh R; Roa JC; Marimuthu A; Riggins GJ; Eshleman JR; Nelkin BD; Pandey A; Maitra A
    Cancer Biol Ther; 2010 Nov; 10(10):1009-18. PubMed ID: 20818175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL.
    Lay JD; Hong CC; Huang JS; Yang YY; Pao CY; Liu CH; Lai YP; Lai GM; Cheng AL; Su IJ; Chuang SE
    Cancer Res; 2007 Apr; 67(8):3878-87. PubMed ID: 17440102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion-related kinase induction of migration requires phosphatidylinositol-3-kinase and ras stimulation of rac activity in immortalized gonadotropin-releasing hormone neuronal cells.
    Nielsen-Preiss SM; Allen MP; Xu M; Linseman DA; Pawlowski JE; Bouchard RJ; Varnum BC; Heidenreich KA; Wierman ME
    Endocrinology; 2007 Jun; 148(6):2806-14. PubMed ID: 17332061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
    Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
    Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival.
    Salian-Mehta S; Xu M; Wierman ME
    Mol Cell Endocrinol; 2013 Jul; 374(1-2):92-100. PubMed ID: 23648337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.
    Choi YJ; Kim JH; Rho JK; Kim JS; Choi CM; Kim WS; Son J; Lee JC
    Oncol Rep; 2017 Apr; 37(4):2201-2208. PubMed ID: 28260071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.
    Song X; Akasaka H; Wang H; Abbasgholizadeh R; Shin JH; Zang F; Chen J; Logsdon CD; Maitra A; Bean AJ; Wang H
    J Biol Chem; 2020 Feb; 295(8):2348-2358. PubMed ID: 31959629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells.
    Son BK; Kozaki K; Iijima K; Eto M; Nakano T; Akishita M; Ouchi Y
    Eur J Pharmacol; 2007 Feb; 556(1-3):1-8. PubMed ID: 17196959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells.
    Konishi A; Aizawa T; Mohan A; Korshunov VA; Berk BC
    J Biol Chem; 2004 Jul; 279(27):28766-70. PubMed ID: 15123721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anexelekto (AXL) Increases Resistance to EGFR-TKI and Activation of AKT and ERK1/2 in Non-Small Cell Lung Cancer Cells.
    Tian Y; Zhang Z; Miao L; Yang Z; Yang J; Wang Y; Qian D; Cai H; Wang Y
    Oncol Res; 2016; 24(5):295-303. PubMed ID: 27712586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis.
    Lee WP; Wen Y; Varnum B; Hung MC
    Oncogene; 2002 Jan; 21(3):329-36. PubMed ID: 11821945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.
    Leconet W; Larbouret C; Chardès T; Thomas G; Neiveyans M; Busson M; Jarlier M; Radosevic-Robin N; Pugnière M; Bernex F; Penault-Llorca F; Pasquet JM; Pèlegrin A; Robert B
    Oncogene; 2014 Nov; 33(47):5405-14. PubMed ID: 24240689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer.
    Liu YN; Tsai MF; Wu SG; Chang TH; Tsai TH; Gow CH; Chang YL; Shih JY
    Int J Cancer; 2019 Sep; 145(6):1609-1624. PubMed ID: 31162839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.